Neurology
FDA/CDC
FDA panel unanimously endorses lecanemab for Alzheimer’s
An intravenous infusion targeting amyloid-beta, lecanemab received accelerated FDA approved earlier in 2023 for the treatment of early Alzheimer’s...
From the Journals
Muscle fat: A new risk factor for cognitive decline?
“Increasing adiposity – or fat deposition – in skeletal muscles predicted faster cognitive decline, irrespective of demographics or other disease...
Latest News
Flavanol supplement improves memory in adults with poor diets
The evidence shows that consuming these nutrients might be associated with the hippocampal-dependent memory component of cognitive aging.
Latest News
Potential new treatment for REM sleep behavior disorder
The disorder can signal risk for synucleinopathies, a group of neurological conditions such as Parkinson's disease that involve the formation of...
News
Ancient plague, cyclical pandemics … history lesson?
Plus: AI detects invisible concussions and a janitor does more than clean.
From the Journals
Younger age of type 2 diabetes onset linked to dementia risk
This new study is the first to examine the effect of diabetes in the relationship between prediabetes and dementia, as well as the age of diabetes...
News
People still want their medical intelligence in human form
Plus: Finding humor in the temporal lobe and comparing reproductive inequality in mammals.
News
Which interventions could lessen the burden of dementia?
The disappearance of hypertension alone from 2020 could decrease dementia prevalence by 21% in men and 16% in women.
From the Journals
Internet use a modifiable dementia risk factor in older adults?
“Online engagement can develop and maintain cognitive reserve – resiliency against physiological damage to the brain – and increased cognitive...
News
Deep sleep may mitigate the impact of Alzheimer’s pathology
“Think of deep sleep almost like a life raft that keeps memory afloat, rather than memory getting dragged down by the weight of Alzheimer’s...
FDA/CDC
FDA approves first drug to treat Alzheimer’s agitation
“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease.”